On December 01st, 2016, Diplomat Pharmacy announced that it will be dispensing DARZALEX® (daratumumab) in combination with REVLIMID® (lenalidomide) and dexamethasone or with VELCADE® (bortezomib) and
-
On December 01st, 2016, Diplomat Pharmacy announced that it will be dispensing DARZALEX
(daratumumab) in combination with REVLIMID
(lenalidomide) and dexamethasone or with VELCADE
(bortezomib) and dexamethasone. DARZALEX was recently approved by the Food and Drug Administration to treat patients with multiple myeloma who have received at least one other treatment.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind